Final answer:
Therapeutic doses of glucocorticoids reduce inflammation and undesirable immune responses by inhibiting antigen presentation, T cell activation, and local mediators, but can also lower infection resistance.
Step-by-step explanation:
Therapeutic doses of glucocorticoids are administered to suppress undesirable immune responses by inhibiting the immune system. This is done through several mechanisms such as: preventing the assembly of antigen peptide-MHC complexes on the surface of antigen-presenting cells, blocking transcription of early T cell activation genes necessary for T cell proliferation, and inhibiting the action of local mediators like lymphokines and prostaglandins. While glucocorticoids such as cortisol, corticosterone, and cortisone help in managing autoimmune diseases by reducing inflammation, they also present the drawback of reduced resistance to infection.